Patents Assigned to PRAZERTHERAPEUTICS INC.
  • NOVEL COMPOUND EXHIBITING ANTI-INFLAMMATORY ACTIVITY AS P38 MAP KINASE INHIBITOR
    Publication number: 20240109839
    Abstract: The present invention relates to a novel compound exhibiting anti-inflammatory activity, and the compound of the present invention plays a key role in the generation of pro-inflammatory cytokines, thereby having excellent inhibitory activity against p38 MAPK, which is known to cause inflammatory diseases, and thus can be effectively used as an agent for treating inflammatory diseases.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 4, 2024
    Applicant: PRAZERTHERAPEUTICS INC.
    Inventors: Kyung-Soo INN, Nam-Jung KIM, Jong Kil LEE, Ga Yeong KIM, Kyeojin KIM, Donghwan KIM, Jimin DO, Chaewon SONG, Na-Rae LEE